| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
IRAM2021Team1 • IRAM 2021 • Mar 2021
Teva Pharmaceutical Industries Ltd (Ticker: Teva, Weight: 5%)
Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. As the opioid crisis fades and settlements are paid there is tremendous upside in Teva’s deeply undervalued stock.
Catalyst: Throughout the pandemic regular medications have gone under-prescribed as doctors have not been able to see patients in person and make clear diagnoses. As the pandemic passes, Teva is positioned for tremendous growth in the generic and non-generic medication sector as people will be more focused on dealing with general ailments.